Methylprednisolone
Brand name: Methylprednisolone
Rank #436 of 500 drugs by total cost
$18.9M
Total Cost
1,934,494
Total Claims
$18.9M
Total Cost
53,419
Prescribers
$10
Cost per Claim
1,618,149
Beneficiaries
1,960,436
30-Day Fills
$353
Avg Cost/Provider
36
Avg Claims/Provider
About Methylprednisolone
Methylprednisolone (sold as Methylprednisolone) was prescribed 1,934,494 times by 53,419 Medicare Part D providers in 2023, costing the program $18.9M. At $10 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 433 | Paroxetine Hcl (Paroxetine Hcl) | $19.2M | 1,226,222 |
| 434 | Naloxone Hcl (Naloxone Hcl) | $19.0M | 232,875 |
| 435 | Elapegademase-Lvlr (Revcovi) | $19.0M | 52 |
| 436 | Methylprednisolone (Methylprednisolone) | $18.9M | 1,934,494 |
| 437 | Sacrosidase (Sucraid) | $18.5M | 1,517 |
| 438 | Enasidenib Mesylate (Idhifa) | $18.1M | 554 |
| 439 | Posaconazole (Posaconazole) | $18.0M | 7,163 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology